Rick Ortiz

Rick Ortiz currently serves as the Chief Financial Officer at AdvaGen Pharma, where responsibilities include leading financial strategy to enhance growth and operational efficiencies in both Generic and Brand spaces since August 2024. Prior to this role, Rick Ortiz worked at Bristol Myers Squibb as the Senior Director of Finance for the Cardiovascular and Established Brands portfolio from September 2020 to August 2024, focusing on strategic financial management. Rick Ortiz also held the position of Head of Finance and Corporate Controller at Lannett Company from April 2010 to September 2020, overseeing corporate finance and accounting functions, along with managing post-acquisition financial integrations. Earlier experience includes serving as Cost Accounting Supervisor at Unique Industries and Sr. Staff Accountant at Fishman and Tobin. Rick Ortiz earned an MBA in Finance from La Salle University and a Bachelor's degree in Accounting from Temple University.